From the Patent Universe

This is a real patent from the public record — curated here so you can explore, research, and analyze real-world IP. It's not currently listed for sale. Own it? Claim it →

medicalSale & License🛒 Fixed Sale 0 views

CRISPR-Cas9 Delivery Vehicle Utilizing Lipid-Based Nanoparticles for Targeted Liver Therapeutics

Patent #US12951448B2

Public record:Verify on Google Patents

A delivery platform for gene-editing reagents specifically engineered to bypass filtration by the spleen and lung tissues. This ensures concentrated therapeutic delivery to hepatic cells for metabolic disorder treatment.

Issue Date

4/20/2026

Inventor

Priya Narayan

Seller Location

United States

Price on request

Real Patent · Not Yet Listed

This patent is showcased from the public record so you can explore real IP. It's not currently for sale — but there are two ways to change that.

Need help with this transaction?

Our team at RocketPatentMe can assist with due diligence, transfer agreements, and legal paperwork.